» Authors » Louis R Cantilena

Louis R Cantilena

Explore the profile of Louis R Cantilena including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 190
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dart R, Bronstein A, Spyker D, Cantilena L, Seifert S, Heard S, et al.
Ann Emerg Med . 2014 Dec; 65(4):416-22. PMID: 25523411
Deaths from drug overdose have become the leading cause of injury death in the United States, where the poison center system is available to provide real-time advice and collect data...
2.
Ko R, Low Dog T, Gorecki D, Cantilena L, Costello R, Evans W, et al.
Nutr Rev . 2014 Apr; 72(3):217-25. PMID: 24697258
This Department of Defense-sponsored evidence-based review evaluates the safety and putative outcomes of enhancement of athletic performance or improved recovery from exhaustion in studies involving beta-alanine alone or in combination...
3.
Miller R, Li Q, Cantilena L, Leary K, Saviolakis G, Melendez V, et al.
Malar J . 2012 Aug; 11:255. PMID: 22853818
Background: Severe malaria results in over a million deaths every year, most of them in children aged less than five years and living in sub-Saharan Africa. Injectable artesunate (AS) was...
4.
Saunders D, Messina J, Darwish M, Xie F, Leary K, Cantilena L
J Clin Pharmacol . 2011 Jun; 52(6):870-9. PMID: 21646442
This exploratory randomized, double-blind, placebo-controlled, 5-treatment, 5-period crossover study was conducted using a thermally induced hyperalgesia pain model in 51 healthy volunteers (33 evaluable) to characterize the relative potency of...
5.
Li Q, Cantilena L, Leary K, Saviolakis G, Miller R, Melendez V, et al.
Am J Trop Med Hyg . 2009 Oct; 81(4):615-21. PMID: 19815876
The pharmacokinetics of good manufacturing process injection of artesunate (AS) were evaluated after single doses at 0.5, 1, 2, 4, and 8 mg/kg with a 2-minute infusion in 40 healthy...
6.
Leary K, Riel M, Roy M, Cantilena L, Bi D, Brater D, et al.
Am J Trop Med Hyg . 2009 Jul; 81(2):356-62. PMID: 19635898
A randomized, double-blind, placebo-controlled study was conducted to assess the effect of tafenoquine, 200 mg weekly for 6 months on ophthalmic and renal safety. This trial was carried out after...
7.
Bi D, Leary K, Weitz J, Cherstniakova S, Reil M, Roy M, et al.
J Chromatogr B Analyt Technol Biomed Life Sci . 2007 Jun; 856(1-2):95-9. PMID: 17599846
A simple and sensitive HPLC-UV assay was developed for the measurement of iothalamate (IOT) in human serum and urine. Chromatographic separation was achieved using an embedded-carbamate-group bonded RP18 column and...
8.
Cantilena L, Cherstniakova S, Saviolakis G, Kahn R, Elkashef A, Rose L, et al.
Contemp Clin Trials . 2007 Jun; 28(6):695-704. PMID: 17544338
The frequency and nature of elevation of liver-associated enzymes (LAE) are important safety endpoints in Phase 1 clinical trials of new anti-cocaine agents, yet very little information is available on...
9.
Roy M, Kraus P, Seegers C, Young S, Kamens D, Law W, et al.
Mayo Clin Proc . 2006 Oct; 81(10):1303-10. PMID: 17036555
Objective: To determine whether short-term human exposure to pyridostigmine bromide, diethyltoluamide, and permethrin, at rest or under stress, adversely affects short-term physical or neurocognitive performance. Participants And Methods: A multicenter,...
10.
Cherstniakova S, Garcia G, Strong J, Bi D, Weitz J, Roy M, et al.
J Anal Toxicol . 2006 Apr; 30(1):21-6. PMID: 16620527
A rapid and highly sensitive gas chromatography-mass spectrometry (GC-MS) method for simultaneous determination of N,N-diethyl-m-toluamide (DEET) and permethrin with (2)H(10)-phenanthrene (98 atom %) as an internal standard and a separate...